|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002871,
umls-concept:C0008976,
umls-concept:C0009566,
umls-concept:C0030705,
umls-concept:C0155626,
umls-concept:C0162577,
umls-concept:C0205087,
umls-concept:C0205225,
umls-concept:C0288672,
umls-concept:C0441994,
umls-concept:C0522523,
umls-concept:C0699733,
umls-concept:C0936012,
umls-concept:C1261322,
umls-concept:C1522318,
umls-concept:C1948041,
umls-concept:C2587213
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2004-9-13
|
|
pubmed:abstractText |
We sought to investigate the impact of anemia in patients with acute myocardial infarction (AMI) undergoing primary percutaneous coronary intervention (PCI).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
pubmed-author:AymongEve DED,
pubmed-author:CohenDavid ADA,
pubmed-author:CoxDavid ADA,
pubmed-author:GarciaEulogioE,
pubmed-author:GriffinJohn JJJ,
pubmed-author:GrinesCindy LCL,
pubmed-author:GuagliumiGiulioG,
pubmed-author:HalkinAmirA,
pubmed-author:LanskyAlexandra JAJ,
pubmed-author:MehranRoxanaR,
pubmed-author:NegoitaManuelaM,
pubmed-author:NikolskyEugeniaE,
pubmed-author:StoneGregg WGW,
pubmed-author:StuckeyThomasT,
pubmed-author:TchengJames EJE,
pubmed-author:TurcoMarkM
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
4
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
547-53
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15358018-Aged,
pubmed-meshheading:15358018-Anemia,
pubmed-meshheading:15358018-Angioplasty, Balloon, Coronary,
pubmed-meshheading:15358018-Antibodies, Monoclonal,
pubmed-meshheading:15358018-Blood Component Transfusion,
pubmed-meshheading:15358018-Female,
pubmed-meshheading:15358018-Hematocrit,
pubmed-meshheading:15358018-Hemorrhage,
pubmed-meshheading:15358018-Hospital Mortality,
pubmed-meshheading:15358018-Humans,
pubmed-meshheading:15358018-Immunoglobulin Fab Fragments,
pubmed-meshheading:15358018-Incidence,
pubmed-meshheading:15358018-Male,
pubmed-meshheading:15358018-Middle Aged,
pubmed-meshheading:15358018-Multivariate Analysis,
pubmed-meshheading:15358018-Myocardial Infarction,
pubmed-meshheading:15358018-Platelet Aggregation Inhibitors,
pubmed-meshheading:15358018-Predictive Value of Tests,
pubmed-meshheading:15358018-Prognosis,
pubmed-meshheading:15358018-Randomized Controlled Trials as Topic,
pubmed-meshheading:15358018-Stents,
pubmed-meshheading:15358018-Stroke,
pubmed-meshheading:15358018-Survival Analysis,
pubmed-meshheading:15358018-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial.
|
|
pubmed:affiliation |
Cardiovascular Research Foundation, New York, New York 10022, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
